Cullinan Therapeutics, Inc. (CGEM)
Nasdaq: CGEM · Biological Products, (No Diagnostic Substances) · Cambridge, MA · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 10, 2026 | Feb 27, 2025 | Mar 14, 2024 | Mar 9, 2023 | Mar 17, 2022 | Mar 30, 2021 |
| Revenue | · | · | · | 0 | 18,943 | 0 |
| Research and development | 187,402 | 142,903 | 148,156 | 91,948 | 57,751 | 43,211 |
| General and administrative | 54,246 | 54,016 | 42,493 | 40,189 | 29,146 | 17,124 |
| Total operating expenses | 241,648 | 196,919 | 190,649 | 132,137 | 86,897 | 60,335 |
| Operating income | -241,648 | -196,919 | -191,089 | 144,648 | -67,954 | -60,335 |
| Interest and investment income | 22,212 | 29,660 | 21,627 | 6,611 | 477 | 888 |
| Other income (expense), net | -443 | -199 | 239 | 57 | -8 | -11 |
| Income before income taxes | -219,879 | -167,458 | -169,223 | 151,316 | -67,485 | · |
| Income tax expense | 0 | 117 | -14,122 | 42,121 | 0 | · |
| Net income including non-controlling interests | -219,879 | -167,575 | -155,101 | 109,195 | -67,485 | -59,458 |
| Net income to non-controlling interests | 0 | -192 | -1,939 | -2,019 | -1,915 | -7,659 |
| Net income | -219,879 | -167,383 | -153,162 | 111,214 | -65,570 | -51,799 |
| Earnings per share, basic | · | · | -3.69 | 2.46 | -1.52 | · |
| Earnings per share, diluted | · | · | -3.69 | 2.38 | -1.52 | · |
| Earnings per share, basic and diluted | · | · | · | · | -1.52 | -2.60 |
| Weighted average shares, basic | · | · | 41,550,000 | 45,164,000 | 43,077,000 | · |
| Weighted average shares, diluted | · | · | 41,550,000 | 46,640,000 | 43,077,000 | · |
| Weighted average shares, basic and diluted | · | · | · | · | 43,077,330 | 19,887,307 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted